conjugate vaccine การใช้

• Currently, Andrew Lees holds 25 patents in the area of conjugate vaccines.
• In the USA, a heptavalent pneumococcal conjugate vaccine ( PCV 7 ) ( e . g.
• The FDA cleared the seven-valent pneumococcal conjugate vaccine for use on Feb . 17, 2000.
• This immune response is less robust than the response provoked by conjugated vaccines, which has several consequences.
• The shortcomings of the polysaccharide vaccine led to the production of the Hib polysaccharide-protein conjugate vaccine.
• After moving to the University of Rochester they developed a polysaccharide conjugate vaccine that worked in infants, too.
• After the success of the Hib vaccine, Schneerson and Robbins continued their work on single antigens and conjugate vaccines.
• After introduction of the pneumococcal conjugate vaccine in 2000, several studies described a decrease in invasive pneumococcal disease in the United States.
• GAVI continues this work and as of March 2013, 25 GAVI-eligible and supported countries have introduced the pneumococcal conjugate vaccine.
• The pneumococcal conjugate vaccine ( PCV13 or Prevnar13 ) protects against the 13 types of bacteria that cause most of the severe illness in children.
• The conjugate vaccine technique Anderson and his colleagues developed led to a Streptococcus pneumoniae ( pneumococcus ) vaccine that was introduced in developed countries 2000.
• This latest method has the potential to significantly reduce costs and create new IP, allowing developing country manufacturers undertake more conjugate vaccine development projects.
• RVF successfully introduced the pneumococcal conjugate vaccine in the West Bank and Gaza, so that all newborns in both territories receive this life-saving vaccine.
• Connaught Laboratories of Swiftwater won a $ 17.5 million contract from the Centers for Disease Control and Prevention in Atlanta for the haemophilus B conjugate vaccine.
• The Centers for Disease Control and Prevention announced Thursday that it is adding a new vaccine, called pneumococcal conjugate vaccine or PCV, to the recommended schedule of childhood immunizations.
• Rappuoli led Chiron Corporation's development of adjuvanted influenza vaccines, MENJUGATE ( R ) conjugate vaccine against meningococcal-C disease and the first recombinant bacterial vaccine against pertussis.
• Vaccines offer significant protection from three to five years ( plain polysaccharide vaccine Menomune, Mencevax and NmVac-4 ) to more than eight years ( conjugate vaccine Menactra ).
• Prevnar is the only pneumococcal conjugate vaccine for infants and children which protects against pneumococcal disease like meningitis, bacterial pneumonia, septicaemia and bacteraemia ( bacteria in the blood .)
• Pneumococcal conjugate vaccines when given during infancy decrease rates of acute otitis media by 6 %  7 % and, if implemented broadly, would have a significant public health benefit.
• People with A-T who are less than two years old should receive three ( 3 ) doses of a pneumococcal conjugate vaccine ( Prevnar ) given at two month intervals.